Abstract
Biliary adenofibroma is a rare tumor with a bile duct origin characterized by a complex tubulocystic non-mucin secreting biliary epithelium with abundant fibrous stroma. The MRI features of biliary adenofibroma are not well established. The authors encountered two patients with biliary adenofibroma and reviewed the literature focusing on the MRI findings. A well-circumscribed multicystic tumor with septal enhancement and no intrahepatic bile duct communication may be the characteristic MRI findings of biliary adenofibroma.
Biliary adenofibroma is an extremely rare biliary epithelial tumor that is characterized by tubulocystic bile duct proliferation lined with non-mucin secreting biliary epithelium and supported by abundant fibroblastic stroma.1 The MRI findings of biliary adenofibroma are not well established owing to its rarity. This paper presents histopathologically confirmed cases of biliary adenofibroma found in two patients who underwent a preoperative MRI, along with a review of the relevant literature focusing on the MRI findings.
A 63-year-old man with chronic hepatitis B and hepatocellular carcinoma treated previously with locoregional therapy was referred to the authors' medical institution for an evaluation of a solitary hepatic lesion increasing in size, as shown on the regular follow-up CT. The patient denied abdominal pain, weight loss, nausea, fever, or jaundice. The laboratory tests revealed a normal liver function. The tumor markers, including alpha-fetoprotein, protein induced by vitamin K absence or antagonist-II, CA 19-9, and CEA, were not elevated.
The CT scans obtained at an outside hospital revealed a tumor size of 1.1×0.7 cm, 2.3×1.4 cm, and 3.6×3.0 cm 5, 3, and 1 year ago, respectively, presenting a slowly growing nature. MRI demonstrated a well-circumscribed multiseptated mass within segments IV and VIII of the liver, measuring 4.7×4.5 cm. The T2-weighted image revealed a multicystic tumor with bright signal intensity (Fig. 1A, B). The precontrast T1-weighted image of the tumor showed low signal intensity (Fig. 1C). After gadolinium administration, thin septa within the tumor were enhanced (Fig. 1D). Communication with the intrahepatic bile ducts was not evident on MRI. No lymphadenopathy was observed.
The patient underwent a central bisegmentectomy. The gross pathological examination showed a well-circumscribed multicystic tumor, measuring 4.5×4.3 cm with thin fibrous septa (Fig. 2A). The tumor was comprised of tubulo-glandular and microcystic structures embedded in the fibrous stroma (Fig. 2B). The tubules and cysts were lined with cuboidal or low columnar epithelial cells. The epithelial component did not contain atypia. The background stroma contained scattered spindle cells. The stroma was fibrous, but ovarian-like stroma was not detected (Fig. 2C). No communication was observed between the lesion and intrahepatic bile ducts, either grossly or microscopically. Immunohistochemically, the epithelial component was positive for cytokeratins 7 and 19, suggesting a bile duct origin. P53 was focally positive. Ki-67/index proliferation was low (<2%). The stromal cells were stained with α-smooth muscle actin (Fig. 2D). The background liver showed septal fibrosis and features of chronic hepatitis consistent with a HBV infection. The patient has been well with no recurrence after a 41-month follow-up period.
A 38-year-old man was referred to the authors' medical institution for an evaluation of a hepatic tumor detected incidentally on a CT scan. A physical examination and laboratory, data including tumor markers, were within the normal range. He denied any personal or family history of hepatobiliary disease.
Abdominal CT revealed a well-circumscribed low attenuation mass within the left lateral section of the liver, measuring 2.7×2.4 cm. MRI revealed a multiseptated multicystic mass with hypointensity on the T1-weighted image and bright signal intensity on the T2-weighted image (Fig. 3A–C). After gadolinium administration, septa and wall enhancement were noted (Fig. 3D). No communication was observed between the lesion and the intrahepatic bile ducts seen on MRI. An enlarged lymph node was not demonstrated.
The patient underwent a left lateral sectionectomy. The gross examination revealed an unencapsulated tumor, measuring 2.5×2.2 cm (Fig. 4A). Microscopically, the tubules were lined with cuboidal or low columnar non-mucin secreting epithelial cells, embedded in a fibrous stroma (Fig. 4B, C). No epithelial atypia was observed. Pathology analysis did not reveal evident communication with the bile ducts. The background liver showed macrovesicular and microvesicular fatty changes. The patient did not develop any recurrence during the 39-month follow-up.
Biliary adenofibroma is a rare primary intrahepatic tumor with an unknown etiology. Tsui et al.1 first described the disease in 1993, and it is now recognized as a distinct tumor of a bile duct origin according to the 2010 World Health Organization (WHO) classification.2 Biliary adenofibroma is characterized by a complex tubulocystic biliary epithelial tumor without mucin production and with abundant fibroblastic stromal components. To the best of the authors' knowledge, only 21 cases of biliary adenofibroma have been reported thus far in the medical literature.1345678910111213141516171819 Previously reported cases focused on the clinical and pathological features of biliary adenofibroma, while the imaging findings were recorded only sporadically. Currently, MRI is the imaging modality of choice for evaluating a range of intrahepatic tumors. MRI has advantages regarding the characterization and diagnosis of these lesions owing to its high contrast resolution. Consequently, the literature was reviewed to characterize the MRI features of biliary adenofibroma.
Table 1 provides brief clinical information and lists the MRI features of the tumor. Biliary adenofibroma occurs in both men and women. The MRI features usually reveal a well-circumscribed multiseptated multicystic tumor that varies in diameter from 2.7 cm to 16 cm. The tumor exhibits hypointensity on the precontrast T1-weighted image and bright signal intensity on the T2-weighted image. After contrast administration, septa and wall enhancement are noted. The present cases also showed no communication with the bile ducts on MRI.
The differential diagnosis for biliary adenofibroma includes intraductal papillary neoplasms of the bile duct (IPNB) and mucinous cystic neoplasm (MCN) of the liver. The tumors grew in a papillary architecture and may be histopathologically similar to biliary adenofibroma.16 On the other hand, mucin secretion was absent in biliary adenofibroma, whereas IPNB and MCN form mucin-containing cysts. The presence of communication between the lesion and the bile duct system is essential for a diagnosis of IPNB. In contrast to IPNB, biliary adenofibroma has no bile duct communication. MCN requires the presence of ovarian-like stroma and occurs almost exclusively in women. Compared to MCN, biliary adenofibroma does not contain ovarian-like stroma. The MRI findings of IPNB and MCN of the liver are well established. The characteristic MRI features of IPNB are visible intraductal masses within the dilated intrahepatic or extrahepatic bile ducts, and the downstream bile duct can also be dilated.2021 Multifocal papillary tumors are well visualized on the T2-weighted image because of the high contrast between the tumor and background bile.22 The imaging patterns of IPNB can be classified into four subtypes according to the presence of intraductal lesions and the degree of mucin production: intraductal mass with proximal ductal dilatation, intraductal mass with proximal and distal ductal dilatation, disproportional duct dilatation without a visible mass, and cystic dilatation with a mass.22 Among them, cystic dilatation with a mass manifests as a focal aneurysmal dilatation of the involved duct or a cystic lesion, showing similar imaging features to biliary adenofibroma. A previous study reported that IPNB could manifest the “thread sign”, which is defined as intraductal linear or curvilinear hypointense striations on MRI.23 On MRI, MCN of the liver typically manifests as a multilocular and septated cystic tumor with an irregular thick wall.24 MRI characterizes intralesional locules with various signal intensities on the T1- and T2-weighted images depending on the cyst fluid protein concentration.25 MCN of the liver does not show dilatation of the downstream bile duct, whereas a ductal dilatation upstream to a cystic lesion can be seen.26
Another differential diagnosis of biliary adenofibroma includes a hepatic echinococcal cyst. Unlike biliary adenofibroma, a typical echinococcal cyst contains multiple daughter cysts. A mother cyst and peripherally located daughter cysts appear as a multilocular cystic lesion with internal septa.27 On MRI, echinococcal cyst shows mixed hypointensity on the T1-weighted image depending on the amount of proteinaceous debris. After contrast administration, the cyst walls and internal septa are enhanced.28
Although biliary adenofibroma is classified as a benign biliary tumor and precursor in the 2019 WHO tumor classification system,29 histopathological and biological spectra of biliary adenofibroma are unclear owing to its rarity. To date, biliary adenofibromas with benign behavior,167813 carcinoma in situ,10 and malignant transformation451214151618 have been reported.
In conclusion, biliary adenofibroma is recognized as a distinct entity of biliary tumor in the WHO classification. The disease is characterized by a tubulocystic bile duct proliferation lined with non-mucin secreting biliary epithelium and supported by abundant fibroblastic stroma. A well-circumscribed multicystic tumor with septal enhancement and no intrahepatic bile duct communication may be the characteristic MRI findings of biliary adenofibroma.
Figures and Tables
Fig. 1
A 63-year-old man with biliary adenofibroma (case 1). (A) Axial and (B) coronal T2-weighted images showed a bright signal intensity tumor with hypointense septa. (C) Axial unenhanced T1-weighted image showed a low signal intensity tumor with a lobulated border. After gadolinium administration, (D) axial delayed phase T1-weighted image showed septal enhancement.
![kjg-74-356-g001](/upload/SynapseData/ArticleImage/0028kjg/kjg-74-356-g001.jpg)
Fig. 2
A 63-year-old man with a biliary adenofibroma (case 1). Gross specimen (A) showed a well-circumscribed multicystic tumor with thin fibrous septa delineating small cysts. (B) The tumor was composed of tubulo-glandular and microcystic structures embedded in the fibrous stroma (H&E, ×40). (C) The tubules and cysts were lined with cuboidal or low columnar biliary epithelial cells. The fibrous stroma contained spindle cells. No ovarian-like stroma was observed (H&E, ×400). (D) Positive immunostaining for α-smooth muscle actin (×100) was observed in the fibrous stroma.
![kjg-74-356-g002](/upload/SynapseData/ArticleImage/0028kjg/kjg-74-356-g002.jpg)
Fig. 3
38-year-old man with biliary adenofibroma (case 2). (A) Axial and (B) coronal T2-weighted images showed a multilobulated and multiseptated cystic tumor. (C) Axial unenhanced T1-weighted image showed a tumor with low signal intensity. (D) Axial portal venous phase T1-weighted image showed septal and wall enhancement.
![kjg-74-356-g003](/upload/SynapseData/ArticleImage/0028kjg/kjg-74-356-g003.jpg)
Fig. 4
38-year-old man with biliary adenofibroma (case 2). Gross specimen (A) showed an unencapsulated tumor with a solid and cystic appearance. (B) Tubulo-glandular structures with fibrous stroma characterized this tumor (H&E, ×40). (C) The tubules were lined with cuboidal or low columnar non-mucin secreting biliary epithelial cells (H&E, ×200).
![kjg-74-356-g004](/upload/SynapseData/ArticleImage/0028kjg/kjg-74-356-g004.jpg)
Notes
References
1. Tsui WM, Loo KT, Chow LT, Tse CC. Biliary adenofibroma. A heretofore unrecognized benign biliary tumor of the liver. Am J Surg Pathol. 1993; 17:186–192.
2. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. 4th ed. Lyon: IARC Press;2010.
3. Parada LA, Bardi G, Hallén M, et al. Monosomy 22 in a case of biliary adenofibroma. Cancer Genet Cytogenet. 1997; 93:183–184.
4. Haberal AN, Bilezikci B, Demirhan B, Karakayali H, Haberal M. Malignant transformation of biliary adenofibroma: a case report. Turk J Gastroenterol. 2001; 12:149–153.
5. Akin O, Coskun M. Biliary adenofibroma with malignant transformation and pulmonary metastases: CT findings. AJR Am J Roentgenol. 2002; 179:280–281.
6. Garduño-López AL, Mondragón-Sánchez R, Bernal-Maldonado R, Hinojosa-Becerril CA, Meneses-García A. A case of biliary adenofibroma of the liver causing elevated serum CA 19-9 levels. Rev Oncol. 2002; 4:271–273.
7. Varnholt H, Vauthey JN, Dal Cin P, et al. Biliary adenofibroma: a rare neoplasm of bile duct origin with an indolent behavior. Am J Surg Pathol. 2003; 27:693–698.
8. Gurrera A, Alaggio R, Leone G, Aprile G, Magro G. Biliary adenofibroma of the liver: report of a case and review of the literature. Patholog Res Int. 2010; 2010:504584.
9. Kai K, Yakabe T, Kohya N, et al. A case of unclassified multicystic biliary tumor with biliary adenofibroma features. Pathol Int. 2012; 62:506–510.
10. Nguyen NT, Harring TR, Holley L, Goss JA, O'Mahony CA. Biliary adenofibroma with carcinoma in situ: a rare case report. Case Reports Hepatol. 2012; 2012:793963.
11. Tsutsui A, Bando Y, Sato Y, et al. Biliary adenofibroma with ominous features of imminent malignant changes. Clin J Gastroenterol. 2014; 7:441–448.
12. Thai E, Dalla Valle R, Evaristi F, Silini EM. A case of biliary adenofibroma with malignant transformation. Pathol Res Pract. 2016; 212:468–470.
13. Elpek GÖ, Ünal B, BaXMLLink_XYZsorgun CXMLLink_XYZ, Ayik E. A problematic case of unclassified multicystic biliary tumor with adenofibroma features. Turk Patoloji Derg. 2016; 32:60–62.
14. Godambe A, Brunt EM, Fulling KH, Reza Kermanshahi T. Biliary adenofibroma with invasive carcinoma: case report and review of the literature. Case Rep Pathol. 2016; 2016:8068513.
15. Thompson SM, Zendejas-Mummert B, Hartgers ML, et al. Malignant transformation of biliary adenofibroma: a rare biliary cystic tumor. J Gastrointest Oncol. 2016; 7:E107–E112.
16. Kaminsky P, Preiss J, Sasatomi E, Gerber DA. Biliary adenofibroma: a rare hepatic lesion with malignant features. Hepatology. 2017; 65:380–383.
17. Arnason T, Borger DR, Corless C, et al. Biliary adenofibroma of liver: morphology, tumor genetics, and outcomes in 6 cases. Am J Surg Pathol. 2017; 41:499–505.
18. Chua D, Chiow AKH, Ang TL, Wang LM. Malignant transformation arising within unusual and rare hepatic lesions: fibropolycystic disease form of ductal plate malformation and biliary adenofibroma. Int J Surg Pathol. 2018; 26:542–550.
19. Esteban M, Amin J, Hertl M, Jakate S, Singh A. Double trouble: a rare case of concurrent biliary adenofibroma and hepatobiliary mucinous cystic neoplasm. ACG Case Rep J. 2018; 5:e72.
20. Joo I, Lee JM, Yoon JH. Imaging diagnosis of intrahepatic and perihilar cholangiocarcinoma: recent advances and challenges. Radiology. 2018; 288:7–13.
21. Lee S, Kim MJ, Kim S, Choi D, Jang KT, Park YN. Intraductal papillary neoplasm of the bile duct: assessment of invasive carcinoma and long-term outcomes using MRI. J Hepatol. 2019; 70:692–699.
22. Park HJ, Kim SY, Kim HJ, et al. Intraductal papillary neoplasm of the bile duct: clinical, imaging, and pathologic features. AJR Am J Roentgenol. 2018; 211:67–75.
23. Hong GS, Byun JH, Kim JH, et al. Thread sign in biliary intraductal papillary mucinous neoplasm: a novel specific finding for MRI. Eur Radiol. 2016; 26:3112–3120.
24. Soares KC, Arnaoutakis DJ, Kamel I, et al. Cystic neoplasms of the liver: biliary cystadenoma and cystadenocarcinoma. J Am Coll Surg. 2014; 218:119–128.
25. Lewin M, Mourra N, Honigman I, et al. Assessment of MRI and MRCP in diagnosis of biliary cystadenoma and cystadenocarcinoma. Eur Radiol. 2006; 16:407–413.
26. Kim HJ, Yu ES, Byun JH, et al. CT differentiation of mucin-producing cystic neoplasms of the liver from solitary bile duct cysts. AJR Am J Roentgenol. 2014; 202:83–91.
27. Pakala T, Molina M, Wu GY. Hepatic echinococcal cysts: a review. J Clin Transl Hepatol. 2016; 4:39–46.
28. Qian LJ, Zhu J, Zhuang ZG, Xia Q, Liu Q, Xu JR. Spectrum of multilocular cystic hepatic lesions: CT and MR imaging findings with pathologic correlation. Radiographics. 2013; 33:1419–1433.
29. WHO Classification of Tumours Editorial Board. WHO classification of tumours of the digestive system. 5th ed. Lyon: IARC Press;2019.